// company-profile

Summit Therapeutics Inc.

SMMT
ExchangeNasdaqSectorPharmaceutical PreparationsFilings64Insiders12
// api This Summit Therapeutics Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares (net $103.6M). Buying was led by DUGGAN ROBERT W.

// 90-day insight

Over the last 90 days, Summit Therapeutics Inc. insiders bought $103.6M across 6 transactions with no open-market sales.

  • Most active insider: DUGGAN ROBERT W with 2 transactions totaling $51.4M.
  • Largest single purchase: $50.0M by DUGGAN ROBERT W on Jun 12, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Summit Therapeutics Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$2.04B
QoQ change
+11.1%
Reporting period
2026-03-31
#1
BAKER BROS. ADVISORS LP
CIK 1263508
$690.0M
36.4M shares
#2
FMR LLC
CIK 315066
$138.9M
7.3M shares
#3
STATE STREET CORP
CIK 93751
$133.3M
7.0M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 12, 2026DUGGAN ROBERT WSMMT
Purchase
3,810,000$13.12$49.99M
Jun 12, 2026Zanganeh MahkamSMMT
Purchase
3,810,000$13.12$49.99M
Jun 4, 2026Soni Manmeet SinghSMMT
Purchase
25,000$14.46$362K
Jun 4, 2026DUGGAN ROBERT WSMMT
Purchase
100,000$14.60$1.46M
Jun 4, 2026Soni Manmeet SinghSMMT
Purchase
25,000$14.43$361K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.